Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. - Wikidata - awgldk - TriplyDB

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

http://www.wikidata.org/entity/Q36228836

about

Biopersistence and brain translocation of aluminum adjuvants of vaccines Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway Targeting dendritic cells: a promising strategy to improve vaccine effectiveness Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing.Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages Pathways of antigen processing.Monocyte-derived dendritic cells exhibit increased levels of lysosomal proteolysis as compared to other human dendritic cell populations.NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes.Complement modulation of T cell immune responses during homeostasis and disease.Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources.Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions.Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation.The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101.Role of chaperones and FcgammaR in immunogenic death.Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity.The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model Antigen Processing for MHC Class II Presentation via Autophagy.Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity Dendritic cell-based in vitro assays for vaccine immunogenicity.Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.Harnessing the immune system to treat cancer.Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo Mycobacterium tuberculosis and the environment within the phagosome.Interactions of tumor cells with dendritic cells: balancing immunity and tolerance The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells.Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange.MHC class II transport at a glance The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120.

P2860

Q21129422-87AA861B-746B-4BAC-A383-C1343B9DBAD7 Q24653956-42115277-238C-4CF2-B588-E00F9FECD8F3 Q26746162-0564F24E-7BDD-4083-AA2C-5347BB07FBA0 Q26781215-BA13B259-01BC-4921-9308-45C9E6273E74 Q27306708-D3644BFD-FE28-4930-B431-7A2CB9087214 Q27677139-F8B40ADA-5B1E-4236-926F-07575BE96FBF Q28742682-27533F27-8349-4A18-A04A-BE4784FD6F38 Q28833624-92709929-327B-4330-953E-FDE200615D1C Q30559146-7EBC1749-5FEB-4523-A1D9-AAE7953B9EF2 Q33422720-9BA82626-A1C7-4F6E-8605-3114A7A3C5B4 Q33631854-7612348D-7779-4DDE-88B3-B0B14023A74A Q33651251-AD25231E-9A4E-4C61-807F-F1299626489E Q33935056-A75F0F85-E232-48AA-8301-DE616C981206 Q34341409-89B1AF21-80B6-45CD-852A-A56D6FBCF5C0 Q34561569-AD4639B0-CC56-4BC5-B041-02FB8A5E823F Q34983665-B177FB58-E73D-4009-8A50-D2763F2355A1 Q35077602-151AEA20-C239-4C83-AF03-F105D4BA1D3F Q35225595-2E02CE27-2305-4BE8-8F08-025FAE4E7EF9 Q35575030-65D528C9-9E6F-48AF-AB39-1BC79B183EB7 Q35622999-828F5FFC-35EC-4E85-95D6-663669338D55 Q35747230-C8E3EBCD-6874-4D19-A8A5-319A8F00D45B Q35913706-4FA95323-FEA0-4463-BCEE-DA3EBCA40567 Q35913709-E0F24533-6DB3-442F-961E-CAA204C98A5C Q35918800-C3F7AEDC-1E82-40EB-8DB2-43C1D44DC474 Q35928311-8ACFB583-C5AD-438D-B0DE-A09E9AA45BB1 Q36007039-9D2CD445-CCAD-4E52-8DA6-966A6D7789AA Q36631329-C42EA51C-DBE5-4606-9F97-0A4490AD9048 Q36654119-2FF32F72-0318-485C-9C42-B2633BF3E5CF Q36809755-978588F7-5CD4-4BC4-83F2-999746F3A22A Q36933020-1A4371D2-AA6A-4A52-83D5-D3E6D734F5A3 Q36938592-3A2AE122-2766-4C84-A990-819748194BD8 Q36975749-CC74D729-9685-428D-B28F-D6392767BBC0 Q36990578-B4200C32-CE80-4CFC-9F59-5378EF58BDED Q37054470-E4D723F8-52CB-49C8-BFD6-D4D7B21772E0 Q37097196-130E9014-E1CD-448E-8AD7-CBE6EAF18BAE Q37153675-E8D7ADBC-6549-41B7-85A0-289AC26EBECD Q37224874-2DA1826F-27A7-4BFB-B8A3-764DBEAF2F46 Q37271553-0126C32E-85D2-4F83-9105-55B445A3CDDD Q37327058-9B7F5A22-D44F-4918-B663-F0A92456CD8C Q37373708-96034863-E4C6-4C7C-A5A1-C4D7A0546AD0

P2860

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

http://www.wikidata.org/entity/Q36228836

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@ast

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@en

type

label

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@ast

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@en

prefLabel

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@ast

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@en

P1433

Q36228836-4B0649F4-555F-4B4C-9157-E6FD112F76AB

P1476

Q36228836-C38B06FA-90E5-447B-99F4-DEE63F2D0E0B

P2093

Q36228836-7A09ABCB-BBF5-4944-A011-F3B63028C483

Q36228836-A7231F7C-7915-43F7-B161-0C81F5921943

Q36228836-CCDA5263-5641-4F75-AE16-101DF5D0665E

Q36228836-D6D8AE53-05F3-4D92-82E0-E71809A57091

P2860

Q36228836-01C5F3B1-4F96-411B-87A0-5D8AAA2CDD64

Q36228836-0D63AD4F-912F-4429-A995-432026DDF82D

Q36228836-0F216648-A94F-42BF-9CBA-203E22646BE6

Q36228836-15A1A922-99F1-42C7-9FD5-338CB4E886F0

Q36228836-216E8FE9-615B-489F-A812-6F7254BCAEE7

Q36228836-29C5719F-E04B-4E6A-9A40-78128D546EDA

Q36228836-2EA2B99C-0D4D-4E65-9B52-AD821B6858D4

Q36228836-3348106E-693F-417F-8C3C-57DD47FB439F

Q36228836-392BE183-A3AA-4213-AEDD-220E2ED1F48E

Q36228836-3FCB8052-E629-4EB0-A287-05E32674571E

P304

Q36228836-E28D9B3E-46A3-4DB6-B772-F1BD4846A557

P31

Q36228836-4EBFAF71-E412-423A-9378-019582F5B2CD

P356

Q36228836-E9316C48-C570-4939-B3F2-ABCFF043DD92

P407

Q36228836-5EF6E9A3-BA00-431E-BA76-0DDD6C53F9E2

P433

Q36228836-7F159EF6-C12C-494E-BACC-6DA3D7764AE4

P478

Q36228836-03A8BEB7-D415-45BC-9166-54CED61B4D1D

P577

Q36228836-104C544E-699B-4AEA-A20E-E1B1965C2D45

P5875

Q36228836-D6B28182-3878-4302-854F-C9BEE924ECE3

P698

Q36228836-D8CF9EE3-733A-4228-8003-7C0EB27E10ED

P921

Q36228836-7D144B2A-72CA-4BB1-979B-BF4B6B6FDDE5

P932

Q36228836-6C586206-AB95-4284-BA06-055AD0A585C3

P356

P1433

Journal of Experimental Medicine

P1476

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

@en

P2093

E Sergio Trombetta

http://www.w3.org/2001/XMLSchema#string

Ira Mellman

http://www.w3.org/2001/XMLSchema#string

Lélia Delamarre

http://www.w3.org/2001/XMLSchema#string

Rachael Couture

http://www.w3.org/2001/XMLSchema#string

P2860

Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

Refinement of the crystal structure of ribonuclease S. Comparison with and between the various ribonuclease A structures

Dendritic cells and the control of immunity

The preparation of subtilisn-modified ribonuclease and the separation of the peptide and protein components

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Proteolysis in MHC class II antigen presentation: who's in charge?

Cell biology of antigen processing in vitro and in vivo.

p73, the "assistant" guardian of the genome?

Phagocytosis and antigen presentation.

Creation versus destruction of T cell epitopes in the class II MHC pathway.

P304

2049-2055

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20052442

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6878161

http://www.w3.org/2001/XMLSchema#string

P698

16908625

http://www.w3.org/2001/XMLSchema#string

P921

P932

2118388

http://www.w3.org/2001/XMLSchema#string